Erratum: Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia (European Journal of Nuclear Medicine and Molecular Imaging (2005) 32 (84-91) DOI: 10.1007/s00259-004-1621-y);Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 1, 2005, Pages 84-91

  Wyss, Christophe A ^a   Koepfli, Pascal ^a   Namdar, Mehdi ^a   Siegrist, Patrick T ^a   Luscher, Thomas F ^a   Camici, Paolo G ^b   Kaufmann, Philipp A ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Bicycle exercise; Coronary circulation; Endothelium; Nitric oxide synthase; PET

Indexed keywords

ADENOSINE; TETRAHYDROBIOPTERIN; WATER O 15;

ADULT; ARTICLE; BICYCLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; MALE; MATHEMATICAL COMPUTING; POSITRON EMISSION TOMOGRAPHY; SUPINE POSITION; VASCULAR DISEASE;

EID: 12444293722     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1759-7     Document Type: Erratum

References (38)

1. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83:391-401.
2. Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation 1999; 99:475-81.
3. Kaufmann PA, Frielingsdorf J, Mandinov L, Seiler C, Hug R, Hess OM. Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia. Circulation 1998; 97:1348-54.
4. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000; 36:103-9.
5. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986; 73:865-76.
6. Buus NH, Bottcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 2001; 104:2305-10.
7. Stroes E, Kastelein J, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99:41-6.
8. Fukuda Y, Teragawa H, Matsuda K, Yamaguta T, Matsuura H, Chayama K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 2002; 87:264-9.
9. Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK, Kaufmann PA. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J Nucl Med 2003; 44:146-54.
10. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. Influence of altitude exposure on coronary flow reserve. Circulation 2003; 108:1202-7.
11. Walter R, Kaufmann PA, Buck A, et al. Tetrahydrobiopterin increases myocardial blood flow in healthy volunteers: a double-blind, placebo-controlled study. Swiss Med Wkly 2001; 131:91-4.
12. Koepfli P, Hany TF, Wyss CA, et al. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med 2004; 45:537-42.
13. 15O-labeled water and PET. J Nucl Med 1999; 40:1848-56.
14. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schäfers KP, Lüscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000; 102:1233-8.
15. Kaufmann PA, Rimoldi O, Gnecchi-Ruscone T, Bonser RS, Luscher TF, Camici PG. Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans. Circulation 2004 [in press].
16. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92:652-62.
17. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984; 24:175-97.
18. Meyers J, Prakash M, Fröhlicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346:793-801.
19. 13N-ammonia at rest and during exercise. Eur J Nucl Med 1985; 11:246-51.
20. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography [see comments]. Circulation 1989; 80:1328-37.
21. Muller P, Czernin J, Choi Y, et al. Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. Am Heart J 1994; 128:52-68.
22. Nagamachi S, Czernin J, Kim AS, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996; 37:1626-31.
23. Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993; 88:2139-48.
24. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990; 81:772-9.
25. Kaufmann P, Vassalli G, Utzinger U, Hess OM. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine. J Am Coll Cardiol 1995; 26:624-31.
26. Kaufmann P, Mandinov L, Frielingsdorf J, Hess OM. Influence of the culprit lesion on clinical symptoms of coronary artery disease, with special emphasis on exercise data. Coron Artery Dis 1998; 9:185-90.
27. Kaufmann P, Mandinov L, Seiler C, Hess OM. Impact of exercise-induced coronary vasomotion on anti-ischemic therapy. Coron Art Dis 2000; 11:363-9.
28. Frielingsdorf J, Seiler C, Kaufmann P, Vassalli G, Suter T, Hess OM. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation 1996; 93:1380-7.
29. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315:1046-51.
30. Frielingsdorf J, Kaufmann P, Seiler C, Vassalli G, Suter T, Hess OM. Abnormal coronary vasomotion in hypertension: role of coronary artery disease. J Am Coll Cardiol 1996; 28:935-41.
31. Mandinov L, Kaufmann P, Maier W, Hess OM. Flow-dependent vasodilation in the coronary circulation: alterations in diseased states. Semin Interv Cardiol 1998; 3:5-12.
32. Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997; 336:1208-15.
33. Sun D, Huang A, Mital S, et al. Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles. Circulation 2002; 106:550-5.
34. Kaufmann P, Matter C, Mandinov L, Frielingsdorf J, Seiler C, Hess OM. High level of cholesterol increases coronary vasomotor tone during exercise. Coron Artery Dis 2000; 11:459-66.
35. Goto C, Higashi Y, Kimura M, et al. Effect of different intensi-ties of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003; 108:530-5.
36. Uren NG, Camici PG, Melin JA, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032-6.
37. Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88:62-9.
38. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001; 50:151-61.